肾细胞癌的迷宫
The Labyrinth of Renal Cell Carcinoma.
作者信息
Manini Claudia, López José I
机构信息
Department of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy.
Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Institute, University of the Basque Country, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.
出版信息
Cancers (Basel). 2020 Feb 24;12(2):521. doi: 10.3390/cancers12020521.
Abstract
Renal cell carcinoma (RCC) ranks in the top-ten list of malignancies both in males and females [...].
摘要
肾细胞癌（RCC）在男性和女性恶性肿瘤排行榜中均位列前十[……]
相似文献
1
The Labyrinth of Renal Cell Carcinoma.肾细胞癌的迷宫
Cancers (Basel). 2020 Feb 24;12(2):521. doi: 10.3390/cancers12020521.
2
Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies.鉴别儿童和青少年肾细胞癌与其他肾脏恶性肿瘤。
Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26315. Epub 2016 Nov 2.
3
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.肾小管囊性癌与乳头状肾细胞癌密切相关：对病理分类的意义
Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.
4
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌（CAS编号：81-49-2）在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究（饲料喂养研究）
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
5
Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada.加拿大的饮食、维生素或矿物质补充剂与肾细胞癌风险
Cancer Causes Control. 2003 Oct;14(8):705-14. doi: 10.1023/a:1026310323882.
6
[Urologic malignancies in renal transplant candidates and recipients].[肾移植候选者和接受者中的泌尿系统恶性肿瘤]
Prog Urol. 2016 Nov;26(15):1094-1113. doi: 10.1016/j.purol.2016.08.009. Epub 2016 Sep 21.
7
Histopathological characteristics of adult renal tumours: a preliminary report.成人肾肿瘤的组织病理学特征：初步报告。
J Pak Med Assoc. 2011 Mar;61(3):224-8.
8
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.一种具有独特形态学特征的低级别嗜酸细胞瘤性富马酸水合酶缺陷型肾细胞癌，类似于琥珀酸脱氢酶缺陷型肾细胞癌。
Histopathology. 2017 Jul;71(1):42-52. doi: 10.1111/his.13183. Epub 2017 Apr 12.
9
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.个体及家族中肾细胞癌和血液系统恶性肿瘤（主要为淋巴样肿瘤）的发生情况。
Fam Cancer. 2016 Oct;15(4):677-87. doi: 10.1007/s10689-016-9911-7.
10
Renal cell carcinoma in dialysis patients: a single center experience.透析患者中的肾细胞癌：单中心经验
Int J Urol. 2006 Aug;13(8):1045-8. doi: 10.1111/j.1442-2042.2006.01498.x.
引用本文的文献
1
Implications of MTHFD2 expression in renal cell carcinoma aggressiveness.MTHFD2 表达与肾细胞癌侵袭性的关系。
PLoS One. 2024 Feb 29;19(2):e0299353. doi: 10.1371/journal.pone.0299353. eCollection 2024.
2
Pathology of Urologic Cancers.泌尿系统癌症病理学
Cancers (Basel). 2022 Aug 1;14(15):3751. doi: 10.3390/cancers14153751.
3
Misconduct in research integrity: Assessment the quality of systematic reviews in Cochrane urological cancer review group.研究诚信中的不当行为：评估Cochrane泌尿外科癌症综述小组系统评价的质量。
Turk J Urol. 2021 Sep;47(5):392-419. doi: 10.5152/tud.2021.21038.
4
High-Resolution Human Kidney Molecular Histology by Imaging Mass Spectrometry of Lipids.基于脂质成像质谱的高分辨率人类肾脏分子组织学
Anal Chem. 2021 Jul 13;93(27):9364-9372. doi: 10.1021/acs.analchem.1c00649. Epub 2021 Jun 30.
5
Insights into Urological Cancer.泌尿系统癌症洞察
Cancers (Basel). 2021 Jan 8;13(2):204. doi: 10.3390/cancers13020204.
6
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.长链非编码RNA与泌尿生殖系统癌症中的耐药机制
Cancers (Basel). 2020 Aug 3;12(8):2148. doi: 10.3390/cancers12082148.
7
Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices.推进肾细胞癌的科学研究与管理：弥合学术实践与社区实践之间的差距。
J Clin Med. 2020 May 17;9(5):1508. doi: 10.3390/jcm9051508.
本文引用的文献
1
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.CDKN1A mRNA和蛋白表达缺失是嫌色性肾细胞癌患者预后不良的独立预测因素。
Cancers (Basel). 2020 Feb 17;12(2):465. doi: 10.3390/cancers12020465.
2
Deletion of Von Hippel-Lindau Interferes with Hyper Osmolality Induced Gene Expression and Induces an Unfavorable Gene Expression Pattern.冯·希佩尔-林道基因的缺失会干扰高渗诱导的基因表达，并诱导出不良的基因表达模式。
Cancers (Basel). 2020 Feb 12;12(2):420. doi: 10.3390/cancers12020420.
3
Sequential treatment of metastatic renal cancer in a complex evolving landscape.在复杂多变的情况下对转移性肾癌进行序贯治疗。
Ann Transl Med. 2019 Dec;7(Suppl 8):S272. doi: 10.21037/atm.2019.12.05.
4
NK Cell-Based Immunotherapy in Renal Cell Carcinoma.基于自然杀伤细胞的免疫疗法在肾癌中的应用
Cancers (Basel). 2020 Jan 29;12(2):316. doi: 10.3390/cancers12020316.
5
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In Vitro.低剂量姜黄素联合可见光照射可抑制肾细胞癌的体外转移行为。
Cancers (Basel). 2020 Jan 28;12(2):302. doi: 10.3390/cancers12020302.
6
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma.EVI1作为透明细胞肾细胞癌的预后和预测生物标志物
Cancers (Basel). 2020 Jan 28;12(2):300. doi: 10.3390/cancers12020300.
7
In-Depth Mapping of the Urinary -Glycoproteome: Distinct Signatures of ccRCC-related Progression.尿糖蛋白组的深度图谱：ccRCC相关进展的独特特征
Cancers (Basel). 2020 Jan 18;12(1):239. doi: 10.3390/cancers12010239.
8
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.肿瘤组织切片的体外治疗作为一种预测性临床前方法，用于评估肾癌患者的靶向治疗
Cancers (Basel). 2020 Jan 17;12(1):232. doi: 10.3390/cancers12010232.
9
ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification.ESC、ALK、HOT和LOT：叩响世界卫生组织分类之门的新兴肾脏实体的三个字母首字母缩写词。
Cancers (Basel). 2020 Jan 9;12(1):168. doi: 10.3390/cancers12010168.
10
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma.基于免疫疗法的联合治疗在转移性肾细胞癌中的未来
Cancers (Basel). 2020 Jan 7;12(1):143. doi: 10.3390/cancers12010143.
Zotero 插件